The use of a chimeric antigen for Plasmodium falciparum and P. vivax seroprevalence estimates from community surveys in Ethiopia and Costa Rica. [PDF]
McCaffery JN +9 more
europepmc +1 more source
Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination. [PDF]
Wongsurawat T +10 more
europepmc +1 more source
Reply to Deora et al. Multiplexing for Plasmodium spp.? Think Again! Comment on "Bhowmick et al. Dry Post Wintertime Mass Surveillance Unearths a Huge Burden of P. vivax, and Mixed Infection with P. vivaxP. falciparum, a Threat to Malaria Elimination, in Dhalai, Tripura, India. Pathogens 2021, 10, 1259". [PDF]
Pal-Bhowmick I +25 more
europepmc +1 more source
VAR2CSA-reactive IgG in Brazilian women exposed to <i>Plasmodium falciparum</i> or <i>P. vivax</i> infection during pregnancy. [PDF]
Dos Santos MI +6 more
europepmc +1 more source
Diagnostic performance of a 5-plex malaria immunoassay in regions co-endemic for Plasmodium falciparum, P. vivax, P. knowlesi, P. malariae and P. ovale. [PDF]
Kho S +10 more
europepmc +1 more source
Drug Resistance of Imported <i>P. falciparum</i> and <i>P. vivax</i> Isolates - China, 2021-2023. [PDF]
Yan H +5 more
europepmc +1 more source
Household costs associated with zoonotic Plasmodium knowlesi, P. falciparum, P. vivax and P. malariae infections in Sabah, Malaysia. [PDF]
Abraham P +10 more
europepmc +1 more source
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-Phosphogluconolactonase. [PDF]
Berneburg I +21 more
europepmc +1 more source
Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax. [PDF]
Cao Y +7 more
europepmc +1 more source
Humoral and cellular immune response to Plasmodium vivax VIR recombinant and synthetic antigens in individuals naturally exposed to P. vivax in the Republic of Korea. [PDF]
Lee S, Choi YK, Goo YK.
europepmc +1 more source

